Recent Advances in B Cells: Signal Transduction and Therapeutic Potential
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 2041
Special Issue Editor
Interests: regulation of the immune response; B cells; signaling; receptor cross-talk; regulatory cells; autoimmunity; rheumatoid arthritis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
B cells play a critical role in the development of effective immune response; they differentiate into plasma cells or memory B cells, secrete high affinity antibodies and a variety of cytokines, provide long-lasting memory, present antigens to T cells and regulate immune responses. However, B cells can also cause diseases through recognizing and reacting to self. B cells must be educated to differentiate self from non-self; thus, they go through several developmental checkpoints where self-specific cells are eliminated. These checkpoints are under the control of B cell receptor (BCR) mediated signals, but also influenced by Toll-like receptor 7 (TLR-7) and TLR-9, the innate immune sensors. BCR, TLR-7, TLR-9 and possibly other receptors function together to regulate the pathogenesis of autoimmunity.
Dysregulated B cell signaling can be the primary driver of many human autoimmune diseases. Studying signaling and co-signaling molecules and pathways in B cells would help to elucidate the molecular mechanisms of autoimmune diseases and would lead to the discovery of novel therapeutic targets and to the development of new drugs for the treatment of autoimmune diseases.
This Special Issue, “Recent Advances in B Cells: Signal Transduction and Therapeutic Potential” in the International Journal of Molecular Sciences will comprise a selection of research papers and reviews that will contribute to defining proteins and signaling pathways that support atypical B cell response in autoimmune diseases. This will also help researchers to better understand disease mechanisms, to identify key immune regulatory processes, and eventually, provide new ideas for precision therapy.
Prof. Dr. Gabriella Sármay
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Anergy
- Autoimmune diseases
- B cell signaling
- Central tolerance
- Extrafollicular response
- Germinal center
- Immune regulation
- Peripheral tolerance
- Signaling pathways and molecules
- Toll-like receptors
